Codiak BioSciences, Inc.
METHODS OF TREATING TUBERCULOSIS
Last updated:
Abstract:
The present disclosure relates to extracellular vesicles, e.g., exosomes, comprising a cytokine, e.g., Interleukin-12 (IL-12), and, optionally, a TB antigen. Also provided herein are methods of inducing an immune response against Mycobacterium tuberculosis in a subject in need thereof comprising administering an extracellular vesicle comprising a cytokine, e.g., IL-12, and, optionally, a TB antigen.
Status:
Application
Type:
Utility
Filling date:
17 Apr 2020
Issue date:
14 Jul 2022